Healthcare

Imugene Limited (ASX:IMU) is a clinical-stage immuno-oncology company focused on developing cell therapies for cancer treatment. Its lead programme, azer-cel, is an allogeneic CAR-T therapy designed to use donor-derived cells rather than individually manufactured patient cells. This article examines the role of azer-cel trials …

Cochlear Limited (ASX:COH) is a global medical device company focused on implantable hearing solutions. The company develops cochlear implants, sound processors and related services designed to support people with severe hearing loss. This article examines how product innovation and technology development continue to shape …

NeuroScientific Biopharmaceuticals Limited (ASX:NSB) is a Perth-based biotechnology company developing therapeutic platforms in areas including regenerative medicine and inflammatory disease. The company has repositioned its development strategy around StemSmart, a mesenchymal stem cell platform being evaluated for potential applications in immune-related conditions.

SomnoMed Limited (ASX:SOM) is a medical device company focused on oral appliance solutions for obstructive sleep apnoea. The company develops custom-fitted devices designed to help maintain airway openness during sleep. This article reviews SomnoMed’sBusinessmodel, financial progress and the factors shaping its next phase of …

Argent BioPharma Limited (ASX:RGT) is a clinical-stage biotechnology company developing pharmaceutical products across areas including cannabinoid medicine, inflammation and neurological conditions. The company’s CannEpil licensing agreement represents an important step in its commercial strategy, with the arrangement designed to support broader product access while …

Holista CollTech Limited (ASX:HCT) is a research-driven health products company focused on natural ingredients, collagen, dietary supplements and related consumer health solutions. The company’s operations span product development andManufacturingactivities across multiple health product categories. This article reviews the company’sBusinessactivities and the factors influencing its …

Tissue Repair Ltd (ASX:TRP) is a clinical-stage biotechnology company developing regenerative medicine technologies. Its lead investigational product, TR987, is a topical gel based on Glucoprime, a beta-glucan-based active ingredient designed to stimulate immune cells involved in wound healing.